Two-Colour Fluorescence Marker for Neurodegenerative Diseases
Worldwide it is estimated that there are 29 million cases of Alzheimer Disease (AD) and about 4 million of Parkinson's Disease (PD). The world market for AD and PD is estimated to be 14 billion dollars corresponding to an annual growth rate of 20%, making it an very attractive field for R&D to generate novel therapeuticals. Recently, the accumulation of dysfunctional mitochondria has been linked to neurodegenerative diseases, in particular to AD and PD. Scientists at the University of Göttingen have developed a powerful fluorescent marker for Live Cell Imaging to study mitochondrial dysfunctions and for testing novel pharmaceutical products
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Red light therapy for repairing spinal cord injury passes milestone
Patients with spinal cord injury (SCI) could benefit from a future treatment to repair nerve connections using red and near-infrared light. The method, invented by scientists at the University of…
Insect research is revolutionized by technology
New technologies can revolutionise insect research and environmental monitoring. By using DNA, images, sounds and flight patterns analysed by AI, it’s possible to gain new insights into the world of…
X-ray satellite XMM-newton sees ‘space clover’ in a new light
Astronomers have discovered enormous circular radio features of unknown origin around some galaxies. Now, new observations of one dubbed the Cloverleaf suggest it was created by clashing groups of galaxies….
